Purchase Order 75N92019P00329

<p>The National Institute of Arthritis and Musculoskeletal and Skin Diseases awarded a purchase order to Illumina, Inc. for an Illumina NovaSeq 6000 sequencing system valued at $902,700.00 on September 4, 2019. Work is performed in San Diego, California. The purchase order is firm fixed price with no set-aside designation and an ultimate completion date of December 31, 2019. The originating pre-solicitation opportunity was posted June 21, 2019 with a due date of July 5, 2019.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Illumina, Inc. for an MiSeq 2 sequencer assembly (catalog 15033616) valued at $95,931.00 on September 26, 2017, with completion by October 26, 2017. Performance occurs at Bethesda, Maryland 20892. The order is a firm fixed-price acquisition of this proprietary genomic sequencing instrument, no set-aside designation applied.</p>

<p>The National Heart Lung and Blood Institute awarded a purchase order to Illumina, Inc. for a NextSeq 550 sequencing system valued at $224,400 on July 26, 2019. Performance takes place in Bethesda, Maryland. The order was issued under firm fixed-price terms without set-aside designation. The solicitation was posted as a special notice on July 2, 2019, with award following 24 days later.</p>

<p>The National Heart Lung and Blood Institute issued a delivery order to Illumina, Inc. on December 7, 2017, with a ceiling value of $44,198.64 for a HISEQ 3000 SR Cluster Kit.</p> <p>Place of performance is San Diego, CA 92122. The order is firm fixed price with no set-aside designation and an ultimate completion date of September 2, 2020.</p>

The National Heart Lung and Blood Institute issued a $106,101.30 delivery order to Illumina, Inc. on September 2, 2026, for next-generation sequencing kits and reagents to support the NHLBI Sequencing Core Facility. Place of performance is San Diego, California. The order is firm fixed price with an ultimate completion date of September 2, 2026. The delivery order procures Illumina sequencing kits and reagents required to conduct next-generation sequencing on Illumina instruments for supported...

<p>The National Heart Lung and Blood Institute issued an $82,024.32 delivery order to Illumina, Inc. on August 6, 2020, for Illumina sequencing kits and reagents supporting next-generation sequencing on Illumina instruments at the NHLBI Sequencing Core Facility.</p> <p>Place of performance is San Diego, CA 92122. The order is firm fixed price with an ultimate completion date of September 2, 2020.</p>

<p>The National Heart Lung and Blood Institute issued a delivery order to Illumina, Inc. on December 26, 2017, for Illumina sequencing reagents to perform DNA sequencing services, with a ceiling value of $50,617.30.</p> <p>Place of performance is San Diego, CA 92121. The order has a firm fixed price structure and an ultimate completion date of September 2, 2020. No set-aside was used.</p>

<p>The National Heart Lung and Blood Institute issued a $139,090.77 delivery order to Illumina, Inc. on May 24, 2019, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is San Diego, CA 92122. The order has an ultimate completion date of September 2, 2020. The delivery is priced on a firm fixed-price basis with no set-aside applied.</p>

<p>The National Heart Lung and Blood Institute issued a delivery order to Illumina, Inc. on May 3, 2019, with a ceiling value of $30,316.04 for genetic sequencing equipment and reagents.</p> <p>Place of performance is San Diego, CA 92122. The order has a firm fixed price structure and an ultimate completion date of September 2, 2020. No set-aside was used.</p>

<p>The National Heart Lung and Blood Institute issued a $31,987.71 delivery order to Illumina, Inc. on May 23, 2019, for genetic sequencing and genomic analysis equipment and services, with ultimate completion by September 2, 2020.</p> <p>Place of performance is San Diego, CA 92122. The order is firm fixed-price with no set-aside designation.</p>